Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Bulletin Du Cancer
|
December 31, 2021
Ingrid Garberis, Fabrice Andre, Magali Lacroix-Triki
Oral Oncology
|
July 18, 2016
Concurrent chemoradiotherapy with cisplatin or cetuximab for locally advanced head and neck squamous cell carcinomas: Does human papilloma virus play a role?
Dan Ou, Antonin Levy, Pierre Blanchard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 29, 2017
Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy
Dan Ou, Ingrid Garberis, Julien Adam, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 3, 2018
Influence of tumor-associated macrophages and HLA class I expression according to HPV status in head and neck cancer patients receiving chemo/bioradiotherapy
Dan Ou, Julien Adam, Ingrid Garberis, et al.
Oncoimmunology
|
September 22, 2017
Clinical relevance of tumor infiltrating lymphocytes, PD-L1 expression and correlation with HPV/p16 in head and neck cancer treated with bio- or chemo-radiotherapy
Dan Ou, Julien Adam, Ingrid Garberis, et al.
Breast Cancer Research and Treatment
|
October 29, 2018
Combinatorial expression of microtubule-associated EB1 and ATIP3 biomarkers improves breast cancer prognosis
Sylvie Rodrigues-Ferreira, Anne Nehlig, Clarisse Monchecourt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 22, 2023
Comparative Genomic Profiling of Second Breast Cancers following First Ipsilateral Hormone Receptor-Positive Breast Cancers
Elie Rassy, Ingrid Garberis, Alicia Tran-Dien, et al.
Oral Oncology
|
July 10, 2017
Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status
Dan Ou, Pierre Blanchard, Silvia Rosellini, et al.
Nature Medicine
|
January 19, 2021
Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial
Thomas Bachelot, Thomas Filleron, Ivan Bieche, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Bulletin Du Cancer
|
December 31, 2021
Ingrid Garberis, Fabrice Andre, Magali Lacroix-Triki
Oral Oncology
|
July 18, 2016
Concurrent chemoradiotherapy with cisplatin or cetuximab for locally advanced head and neck squamous cell carcinomas: Does human papilloma virus play a role?
Dan Ou, Antonin Levy, Pierre Blanchard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 29, 2017
Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy
Dan Ou, Ingrid Garberis, Julien Adam, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 3, 2018
Influence of tumor-associated macrophages and HLA class I expression according to HPV status in head and neck cancer patients receiving chemo/bioradiotherapy
Dan Ou, Julien Adam, Ingrid Garberis, et al.
Oncoimmunology
|
September 22, 2017
Clinical relevance of tumor infiltrating lymphocytes, PD-L1 expression and correlation with HPV/p16 in head and neck cancer treated with bio- or chemo-radiotherapy
Dan Ou, Julien Adam, Ingrid Garberis, et al.
Breast Cancer Research and Treatment
|
October 29, 2018
Combinatorial expression of microtubule-associated EB1 and ATIP3 biomarkers improves breast cancer prognosis
Sylvie Rodrigues-Ferreira, Anne Nehlig, Clarisse Monchecourt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 22, 2023
Comparative Genomic Profiling of Second Breast Cancers following First Ipsilateral Hormone Receptor-Positive Breast Cancers
Elie Rassy, Ingrid Garberis, Alicia Tran-Dien, et al.
Oral Oncology
|
July 10, 2017
Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status
Dan Ou, Pierre Blanchard, Silvia Rosellini, et al.
Nature Medicine
|
January 19, 2021
Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial
Thomas Bachelot, Thomas Filleron, Ivan Bieche, et al.
Page
of 1